SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹41,238 Cr | ₹34,400 Cr | ₹26,449 Cr | ₹19,956 Cr | ₹17,656 Cr |
What is the latest Net Current Assets ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹41,238 Cr |
| Mar2025 | ₹34,400 Cr |
| Mar2024 | ₹26,449 Cr |
| Mar2023 | ₹19,956 Cr |
| Mar2022 | ₹17,656 Cr |
How is Net Current Assets of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹41,238 Cr | 19.88 | |
| Mar2025 | ₹34,400 Cr | 30.06 | |
| Mar2024 | ₹26,449 Cr | 32.54 | |
| Mar2023 | ₹19,956 Cr | 13.02 | |
| Mar2022 | ₹17,656 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,269.8 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
| MANKIND PHARMA | ₹104,913.0 Cr | 2.7% | 1.8% | 5.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 5.2% |
4.3% |
8% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses